These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16644881)

  • 1. Comparison of gene-expression profiles in parallel bone marrow and peripheral blood samples in acute myeloid leukaemia by real-time polymerase chain reaction.
    Sakhinia E; Farahangpour M; Tholouli E; Liu Yin JA; Hoyland JA; Byers RJ
    J Clin Pathol; 2006 Oct; 59(10):1059-65. PubMed ID: 16644881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow.
    Sakhinia E; Faranghpour M; Liu Yin JA; Brady G; Hoyland JA; Byers RJ
    Br J Haematol; 2005 Jul; 130(2):233-48. PubMed ID: 16029452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiling of microarray gene signatures in acute and chronic myeloid leukaemia in human bone marrow.
    Sakhinia E; Estiar MA; Andalib S; Rezamand A
    Iran J Ped Hematol Oncol; 2015; 5(1):27-42. PubMed ID: 25914800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal-mediated down-regulation of CD13 in bone marrow cells originating from acute myeloid leukemia patients.
    Dybkaer K; Olesen G; Pedersen FS; Kristensen JS
    Eur J Haematol; 2001 Mar; 66(3):168-77. PubMed ID: 11350485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of transferrin receptor 2 mRNA, not transferrin receptor 1 mRNA, are associated with increased survival in acute myeloid leukaemia.
    Nakamaki T; Kawabata H; Saito B; Matsunawa M; Suzuki J; Adachi D; Tomoyasu S; Phillip Koeffler H
    Br J Haematol; 2004 Apr; 125(1):42-9. PubMed ID: 15015967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
    Ovcharenko D; Stölzel F; Poitz D; Fierro F; Schaich M; Neubauer A; Kelnar K; Davison T; Müller-Tidow C; Thiede C; Bornhäuser M; Ehninger G; Brown D; Illmer T
    Exp Hematol; 2011 Oct; 39(10):1030-1042.e7. PubMed ID: 21784052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia.
    Xiang L; Li M; Liu Y; Cen J; Chen Z; Zhen X; Xie X; Cao X; Gu W
    Ann Hematol; 2013 Aug; 92(8):1063-9. PubMed ID: 23515710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study.
    Willasch AM; Gruhn B; Coliva T; Kalinova M; Schneider G; Kreyenberg H; Steinbach D; Weber G; Hollink IH; Zwaan CM; Biondi A; van der Velden VH; Reinhardt D; Cazzaniga G; Bader P; Trka J;
    Leukemia; 2009 Aug; 23(8):1472-9. PubMed ID: 19322206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies.
    Yokoyama A; Okabe-Kado J; Wakimoto N; Kobayashi H; Sakashita A; Maseki N; Nakamaki T; Hino Ki; Tomoyasu S; Tsuruoka N; Motoyoshi K; Nagata N; Honma Y
    Blood; 1998 Mar; 91(6):1845-51. PubMed ID: 9490665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low levels of ABCG2 expression in adult AML blast samples.
    Abbott BL; Colapietro AM; Barnes Y; Marini F; Andreeff M; Sorrentino BP
    Blood; 2002 Dec; 100(13):4594-601. PubMed ID: 12393637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of HOXA9, DEK, CBL and CSF1R in acute myeloid leukemia.
    Casas S; Nagy B; Elonen E; Aventín A; Larramendy ML; Sierra J; Ruutu T; Knuutila S
    Leuk Lymphoma; 2003 Nov; 44(11):1935-41. PubMed ID: 14738146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia.
    Inoue K; Sugiyama H; Ogawa H; Nakagawa M; Yamagami T; Miwa H; Kita K; Hiraoka A; Masaoka T; Nasu K
    Blood; 1994 Nov; 84(9):3071-9. PubMed ID: 7949179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study.
    Østergaard M; Olesen LH; Hasle H; Kjeldsen E; Hokland P
    Br J Haematol; 2004 Jun; 125(5):590-600. PubMed ID: 15147374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia.
    Jurlander J; Caligiuri MA; Ruutu T; Baer MR; Strout MP; Oberkircher AR; Hoffmann L; Ball ED; Frei-Lahr DA; Christiansen NP; Block AM; Knuutila S; Herzig GP; Bloomfield CD
    Blood; 1996 Sep; 88(6):2183-91. PubMed ID: 8822938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia.
    Müller-Tidow C; Metzelder SK; Buerger H; Packeisen J; Ganser A; Heil G; Kügler K; Adigüzel G; Schwäble J; Steffen B; Ludwig WD; Heinecke A; Büchner T; Berdel WE; Serve H
    Leukemia; 2004 Apr; 18(4):720-6. PubMed ID: 14973498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of cancer cells disseminated in bone marrow using real-time quantitative RT-PCR of CEA, CK19, and CK20 mRNA in patients with gastric cancer.
    Fujita Y; Terashima M; Hoshino Y; Ohtani S; Kashimura S; Kanzaki N; Osuka F; Kogure M; Gotoh M
    Gastric Cancer; 2006; 9(4):308-14. PubMed ID: 17235634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome.
    Bergmann L; Miething C; Maurer U; Brieger J; Karakas T; Weidmann E; Hoelzer D
    Blood; 1997 Aug; 90(3):1217-25. PubMed ID: 9242555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of quantitative assessment of Wilms tumour gene 1 for monitoring of residual disease in acute myeloid leukemia patients].
    Polák J; Marková J; Schwarz J; Maaloufová J; Volková Z; Cermák J; Haskovec C
    Cas Lek Cesk; 2006; 145(1):36-42. PubMed ID: 16468240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the p53 and MDM-2 gene in acute myeloid leukemia.
    Seliger B; Papadileris S; Vogel D; Hess G; Brendel C; Störkel S; Ortel J; Kolbe K; Huber C; Huhn D; Neubauer A
    Eur J Haematol; 1996 Sep; 57(3):230-40. PubMed ID: 8898928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.